The University of Edinburgh, Edinburgh, UK.
Manchester Centre for Health Economics, The University of Manchester, Manchester, UK.
Syst Rev. 2018 Sep 15;7(1):142. doi: 10.1186/s13643-018-0803-9.
Estimates of survival for women diagnosed with early staged breast cancer are available based on stratification into prognostic categories defined using the Nottingham Prognostic Index (NPI). This review aimed to identify and summarize the estimated survival statistics from separate sources in the literature and to explore the extent of between-study heterogeneity in survival estimates.
Observational studies in women diagnosed with early and locally advanced breast cancer reporting overall survival by NPI category were identified using a systematic literature search. An exploratory meta-analysis was conducted to describe survival estimates and assess between-study heterogeneity.
Twenty-eight studies were identified. Nineteen studies with sufficient data on overall survival were included in meta-analysis. A high level of heterogeneity in survival estimates was evident with I values in the range of 90 to 98%.
The substantial differences between studies in the relationship between NPI categories and survival at 5 and 10 years poses challenges for use of this prognostic score in both clinical settings and in decision-analytic model-based economic evaluations.
基于使用诺丁汉预后指数(NPI)定义的预后类别分层,可获得诊断为早期乳腺癌的女性的生存估计。本综述旨在从文献中的不同来源中确定和总结估计的生存统计数据,并探讨生存估计中研究间异质性的程度。
使用系统文献检索,确定了诊断为早期和局部晚期乳腺癌的女性的观察性研究,这些研究报告了 NPI 分类的总体生存率。进行探索性荟萃分析以描述生存估计并评估研究间的异质性。
确定了 28 项研究。有 19 项研究具有足够的总体生存数据,纳入荟萃分析。生存估计存在高度异质性,I 值在 90%至 98%之间。
NPI 类别与 5 年和 10 年生存之间的关系在研究之间存在很大差异,这对该预后评分在临床环境和基于决策分析模型的经济评估中的使用提出了挑战。